Nervonik is a medical device company developing non-invasive peripheral nerve stimulation systems for chronic pain management and neurological rehabilitation. The platform delivers targeted transcutaneous electrical stimulation to peripheral nerve pathways without requiring implants, using precision electrode placement and proprietary stimulation waveforms designed to maximise nerve activation specificity.

The system targets patients with chronic pain conditions and neurological deficits who seek non-pharmacological treatment options without surgical implant risk. The non-invasive approach enables self-administration at home following initial clinician programming.

Nervonik competes in the wearable non-invasive nerve stimulation market alongside Cefaly, Theranica, and established TENS companies, differentiating through its emphasis on nerve-specific targeting and clinical evidence development.